Gliclazide and Burkitt lymphoma - a phase IV clinical study of FDA data

Summary:

Burkitt lymphoma is reported as a side effect among people who take Gliclazide (gliclazide), especially for people who are male, 60+ old, also take Enbrel, and have Dyslipidaemia.

The phase IV clinical study analyzes which people have Burkitt lymphoma when taking Gliclazide. It is created by eHealthMe based on reports of 27,903 people who have side effects when taking Gliclazide from the FDA, and is updated regularly.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

What is Burkitt lymphoma?

Burkitt lymphoma (cancer of the lymphatic system) is found to be associated with 374 drugs and 811 conditions by eHealthMe. Check the latest studies of Burkitt lymphoma.

On Aug, 03, 2026

27,903 people reported to have side effects when taking Gliclazide.
Among them, 16 people (0.06%) have Burkitt lymphoma.

Could Gliclazide cause Burkitt lymphoma?

Among these 16 people:

What is the gender of people who have Burkitt lymphoma when taking Gliclazide? *

female: 0.0 %
male: 100 %

What is the age of people who have Burkitt lymphoma when taking Gliclazide? *

What are other drugs people take besides Gliclazide? *

Taltz: 14 people, 87.50%
Onglyza: 14 people, 87.50%
Irbesartan: 14 people, 87.50%
Enbrel: 14 people, 87.50%
Enstilar: 13 people, 81.25%
Metformin Hydrochloride: 8 people, 50.00%
Metformin: 6 people, 37.50%
Methotrexate: 2 people, 12.50%
Humira: 2 people, 12.50%
Folic Acid: 2 people, 12.50%

What are other side effects people have besides Burkitt lymphoma? *

Renal Cell Carcinoma (a kidney cancer): 14 people, 87.50%
Weakness: 2 people, 12.50%
Vertebral Column Mass (spinal tumour): 2 people, 12.50%
Urinary Retention (the inability to completely or partially empty the bladder): 2 people, 12.50%
Spinal Cord Compression: 2 people, 12.50%
Constipation: 2 people, 12.50%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 6.25%
Joint Instability (a condition in which the joints aren't sufficiently supported): 1 person, 6.25%
Hypoaesthesia (reduced sense of touch or sensation): 1 person, 6.25%
Fall: 1 person, 6.25%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 14 people, 87.50%
High Blood Pressure: 14 people, 87.50%
Dyslipidaemia (abnormal amount of lipids): 14 people, 87.50%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Gliclazide and have Burkitt lymphoma?

- Check whether Burkitt lymphoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gliclazide:

Gliclazide (28,131 reports)

Burkitt lymphoma treatments and more:

Burkitt lymphoma (28,141 reports)

Browse all side effects of Gliclazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Burkitt lymphoma:

Burkitt lymphoma (374 drugs)

Browse all the conditions that are associated with Burkitt lymphoma:

Burkitt lymphoma (811 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gliclazide (the active ingredients of Gliclazide) and Gliclazide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.